Perceptions of facilitators and barriers to national tobacco endgame policies among European stakeholders: a qualitative analysis
Tobacco Control · 2026-04-30 · tc-2024-059063
DOI: 10.1136/tc-2024-059063 ↗At a glance
Journal article in Tobacco Control, published online on 2026-04-30. Written by Gunnar Sæbø and 9 co-authors. Institution: Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway gunnar.saebo@fhi.no. 35 references. Funded by: The European Union’s Health Program, The Ministry of Universities and Research, Government of Catalonia.
Abstract (original language)
Background
The idea of adopting tobacco endgame policies is gaining ground in the tobacco control community. This paper explores European stakeholders’ perceptions and appraisal of facilitators and barriers in achieving national endgame policies.
Methods
Semi-structured qualitative interviews with 23 participants from eight countries with different tobacco control contexts were conducted in 18 individual and two focus group interviews from February to December 2023. Participant selection was based on experience and competence in tobacco control. Participants represented government agencies, research institutes and civil society from Cyprus, Finland, Italy, Lithuania, Norway, Serbia, Slovenia and Spain. Thematic analysis was used to generate key themes.
Results
Facilitators identified for succeeding in pursuing endgame strategies include having a context of favourable international developments and modelling ‘pressure’ on global and regional level, active civil society groups and effective coordination of key players, little or no industry in the country and support across political party lines with strong-willed individuals leading the way. Frequently mentioned barriers are lobbying and strong presence of industry, emergence of new products (often promoted in social media), a stagnated denormalisation process of smoking and few or weak non-governmental organisations.
Conclusion
Structured national network collaboration with a common focus over time, combined with strong engagement from supranational entities, especially the European Union, is needed to proceed with successful implementation and dissemination of tobacco endgame policies in Europe.
Subjects
Author keywords
Authors and institutions
- Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway gunnar.saebo@fhi.no.
- Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway.
- Department of Healthcare and Social Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
- Department of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Helsinki, Finland.
- Catalan Institute of Oncology, L'Hospitalet de Llobregat, Spain.
- Bellvitge Institute for Biomedical Research, Barcelona, Spain.
Funding
- The European Union’s Health Program
- The Ministry of Universities and Research, Government of Catalonia
Cite
APA
Sæbø, G., Lund, I., Ollila, H., Ruokolainen, O., Laatikainen, T., Carnicer-Pont, D., Karekla, M., Georgiou, K., Koprivnikar, H., & Vasic, M. (2026). Perceptions of facilitators and barriers to national tobacco endgame policies among European stakeholders: a qualitative analysis. Tobacco Control, tc-2024-059063. https://doi.org/10.1136/tc-2024-059063
Vancouver
Sæbø G, Lund I, Ollila H, Ruokolainen O, Laatikainen T, Carnicer-Pont D, et al. Perceptions of facilitators and barriers to national tobacco endgame policies among European stakeholders: a qualitative analysis. Tobacco Control. 2026:tc-2024-059063. doi:10.1136/tc-2024-059063
BibTeX
@article{Sb2026,
author = {Sæbø, Gunnar and Lund, Ingeborg and Ollila, Hanna and Ruokolainen, Otto and Laatikainen, Tiina and Carnicer-Pont, Dolors and Karekla, Maria and Georgiou, Katerina and Koprivnikar, Helena and Vasic, Milena},
title = {Perceptions of facilitators and barriers to national tobacco endgame policies among European stakeholders: a qualitative analysis},
journal = {Tobacco Control},
year = {2026},
pages = {tc--2024--059063},
doi = {10.1136/tc-2024-059063}
}
EUVIMED